Published on 29 Mar 2023 on Zacks via Yahoo Finance
3 Medical Stocks Creating Wealth Despite Macro Challenges
The broader U.S. indices, reflecting market sentiments, have been reeling under significant pressure in 2022, with companies from the majority of sectors facing several headwinds like a hawkish Fed, geopolitical issues and lingering COVID-19 uncertainties.
However, several companies managed to buck the trend and created wealth for their investors, driven by strong fundamentals. Some companies also initiated cost-savings programs along with price hikes to fight the rising cost of materials that benefited their margins.
Three stocks — Lantheus LNTH, Omeros OMER and Hyperfine HYPR — have managed to rise nearly or more than 50% year to date in 2023.